Format
Sort by
Items per page

Send to

Choose Destination

Search results

Items: 1 to 50 of 500

1.

Twenty-five years of change in the management of the axilla in breast cancer.

Dixon JM, Cartlidge CWJ.

Breast J. 2019 Dec 19. doi: 10.1111/tbj.13720. [Epub ahead of print]

PMID:
31854498
2.

Estrogen Receptor pathway activity score to predict clinical response or resistance to neo-adjuvant endocrine therapy in primary breast cancer.

Inda MA, Blok EJ, Kuppen PJK, Charehbili A, den Biezen-Timmermans EC, van Brussel A, Fruytier SE, Meershoek-Klein Kranenbarg E, Kloet SL, van der Burg B, Martens JWM, Sims AH, Turnbull AK, Dixon JM, Verhaegh W, Kroep JR, van de Velde CJH, van de Stolpe A.

Mol Cancer Ther. 2019 Nov 14. pii: molcanther.0318.2019. doi: 10.1158/1535-7163.MCT-19-0318. [Epub ahead of print]

PMID:
31727690
3.

Human Tumor-Associated Macrophage and Monocyte Transcriptional Landscapes Reveal Cancer-Specific Reprogramming, Biomarkers, and Therapeutic Targets.

Cassetta L, Fragkogianni S, Sims AH, Swierczak A, Forrester LM, Zhang H, Soong DYH, Cotechini T, Anur P, Lin EY, Fidanza A, Lopez-Yrigoyen M, Millar MR, Urman A, Ai Z, Spellman PT, Hwang ES, Dixon JM, Wiechmann L, Coussens LM, Smith HO, Pollard JW.

Cancer Cell. 2019 Apr 15;35(4):588-602.e10. doi: 10.1016/j.ccell.2019.02.009. Epub 2019 Mar 28.

4.

Higher Insulin Resistance and Adiposity in Postmenopausal Women With Breast Cancer Treated With Aromatase Inhibitors.

Gibb FW, Dixon JM, Clarke C, Homer NZ, Faqehi AMM, Andrew R, Walker BR.

J Clin Endocrinol Metab. 2019 Sep 1;104(9):3670-3678. doi: 10.1210/jc.2018-02339.

5.

Oncoplastic breast conservation occupies a niche between standard breast conservation and mastectomy - A population-based prospective audit in Scotland.

Morrow ES, Stallard S, Doughty J, Malyon A, Barber M, Dixon JM, Romics L.

Eur J Surg Oncol. 2019 Oct;45(10):1806-1811. doi: 10.1016/j.ejso.2019.03.014. Epub 2019 Mar 15.

PMID:
30902354
6.

Accurate Estrogen Receptor Quantification in Patients with Negative and Low-Positive Estrogen-Receptor-Expressing Breast Tumors: Sub-Analyses of Data from Two Clinical Studies.

Dixon JM, Cameron DA, Arthur LM, Axelrod DM, Renshaw L, Thomas JS, Turnbull A, Young O, Loman CA, Jakubowski D, Baehner FL, Singh B.

Adv Ther. 2019 Apr;36(4):828-841. doi: 10.1007/s12325-019-0896-0. Epub 2019 Mar 11.

PMID:
30859501
7.
8.

Molecular changes during extended neoadjuvant letrozole treatment of breast cancer: distinguishing acquired resistance from dormant tumours.

Selli C, Turnbull AK, Pearce DA, Li A, Fernando A, Wills J, Renshaw L, Thomas JS, Dixon JM, Sims AH.

Breast Cancer Res. 2019 Jan 7;21(1):2. doi: 10.1186/s13058-018-1089-5.

9.

Breast implants and anaplastic large cell lymphoma.

Dixon JM, Clemens M.

BMJ. 2018 Nov 30;363:k5054. doi: 10.1136/bmj.k5054. No abstract available.

PMID:
30504242
10.

The evolving role of receptors as predictive biomarkers for metastatic breast cancer.

Martínez-Pérez C, Turnbull AK, Dixon JM.

Expert Rev Anticancer Ther. 2019 Feb;19(2):121-138. doi: 10.1080/14737140.2019.1552138. Epub 2018 Dec 3.

PMID:
30501540
11.

Quality of life after postmastectomy radiotherapy in patients with intermediate-risk breast cancer (SUPREMO): 2-year follow-up results of a randomised controlled trial.

Velikova G, Williams LJ, Willis S, Dixon JM, Loncaster J, Hatton M, Clarke J, Kunkler IH, Russell NS; MRC SUPREMO trial UK investigators.

Lancet Oncol. 2018 Nov;19(11):1516-1529. doi: 10.1016/S1470-2045(18)30515-1. Epub 2018 Oct 15. Erratum in: Lancet Oncol. 2018 Dec;19(12):e668.

12.

Luminophore Formation in Various Conformations of Bovine Serum Albumin by Binding of Gold(III).

Dixon JM, Egusa S.

J Vis Exp. 2018 Aug 31;(138). doi: 10.3791/58141.

PMID:
30222150
13.

The value of 3D images in the aesthetic evaluation of breast cancer conservative treatment. Results from a prospective multicentric clinical trial.

Cardoso MJ, Vrieling C, Cardoso JS, Oliveira HP, Williams NR, Dixon JM; PICTURE Project Clinical Trial Team; PICTURE Project Delphi Panel.

Breast. 2018 Oct;41:19-24. doi: 10.1016/j.breast.2018.06.008. Epub 2018 Jun 18.

PMID:
29940498
14.

A population-based audit of surgical practice and outcomes of oncoplastic breast conservations in Scotland - An analysis of 589 patients.

Romics L, Macaskill EJ, Fernandez T, Simpson L, Morrow E, Pitsinis V, Tovey S, Barber M, Masannat Y, Stallard S, Weiler-Mithoff E, Malyon A, Mansell J, Campbell EJ, Doughty J, Dixon JM.

Eur J Surg Oncol. 2018 Jul;44(7):939-944. doi: 10.1016/j.ejso.2018.04.004. Epub 2018 Apr 13.

PMID:
29705287
15.

Conformational Change-Induced Fluorescence of Bovine Serum Albumin-Gold Complexes.

Dixon JM, Egusa S.

J Am Chem Soc. 2018 Feb 14;140(6):2265-2271. doi: 10.1021/jacs.7b11712. Epub 2018 Feb 2.

PMID:
29361222
16.

Autologous breast reconstruction using the immediately lipofilled extended latissimus dorsi flap.

Johns N, Fairbairn N, Trail M, Ewing A, Yong L, Raine C, Dixon JM.

J Plast Reconstr Aesthet Surg. 2018 Feb;71(2):201-208. doi: 10.1016/j.bjps.2017.10.015. Epub 2017 Nov 24.

PMID:
29239797
17.

Pre-operative Endocrine Therapy.

Arthur LM, Turnbull AK, Khan LR, Dixon JM.

Curr Breast Cancer Rep. 2017;9(4):202-209. doi: 10.1007/s12609-017-0255-6. Epub 2017 Oct 27. Review.

18.

Margin width and local recurrence after breast conserving surgery for ductal carcinoma in situ.

Ekatah GE, Turnbull AK, Arthur LM, Thomas J, Dodds C, Dixon JM.

Eur J Surg Oncol. 2017 Nov;43(11):2029-2035. doi: 10.1016/j.ejso.2017.08.003. Epub 2017 Sep 4.

19.

European interpretation of North American post mastectomy radiotherapy guideline update.

Kunkler IH, Dixon JM, Maclennan M, Russell NS.

Eur J Surg Oncol. 2017 Oct;43(10):1805-1807. doi: 10.1016/j.ejso.2017.04.004. Epub 2017 May 10. No abstract available.

PMID:
28847645
20.

Response Letter.

Brezezinska M, Williams LJ, Thomas J, Dixon JM.

Breast Cancer Res Treat. 2017 Oct;165(3):783-784. doi: 10.1007/s10549-017-4368-4. No abstract available.

PMID:
28698972
21.

Whither surgical quality assurance of breast cancer surgery (surgical margins and local recurrence) after paterson.

Bundred NJ, Thomas J, Dixon JMJ.

Breast Cancer Res Treat. 2017 Oct;165(3):473-475. doi: 10.1007/s10549-017-4369-3. Epub 2017 Jul 5.

PMID:
28681172
22.

Neoadjuvant Therapy in Early Breast Cancer: Treatment Considerations and Common Debates in Practice.

Cain H, Macpherson IR, Beresford M, Pinder SE, Pong J, Dixon JM.

Clin Oncol (R Coll Radiol). 2017 Oct;29(10):642-652. doi: 10.1016/j.clon.2017.06.003. Epub 2017 Jun 29. Review.

23.

Current treatment trends and the need for better predictive tools in the management of ductal carcinoma in situ of the breast.

Martínez-Pérez C, Turnbull AK, Ekatah GE, Arthur LM, Sims AH, Thomas JS, Dixon JM.

Cancer Treat Rev. 2017 Apr;55:163-172. doi: 10.1016/j.ctrv.2017.03.009. Epub 2017 Mar 31. Review.

PMID:
28402908
24.

Immediate lipofilling in breast conserving surgery.

Khan LR, Raine CR, Dixon JM.

Eur J Surg Oncol. 2017 Aug;43(8):1402-1408. doi: 10.1016/j.ejso.2017.03.014. Epub 2017 Mar 27.

PMID:
28390738
25.

Reply to letter to editor: "Intra-operative assessment of excised breast tumour Margins using Clear Edge imaging device".

Dixon JM.

Eur J Surg Oncol. 2017 Aug;43(8):1604-1605. doi: 10.1016/j.ejso.2017.02.011. Epub 2017 Feb 27. No abstract available.

PMID:
28318685
26.

The State of Emergency Medical Services (EMS) Systems in Africa.

Mould-Millman NK, Dixon JM, Sefa N, Yancey A, Hollong BG, Hagahmed M, Ginde AA, Wallis LA.

Prehosp Disaster Med. 2017 Jun;32(3):273-283. doi: 10.1017/S1049023X17000061. Epub 2017 Feb 23.

PMID:
28228178
27.

A PAM50-Based Chemoendocrine Score for Hormone Receptor-Positive Breast Cancer with an Intermediate Risk of Relapse.

Prat A, Lluch A, Turnbull AK, Dunbier AK, Calvo L, Albanell J, de la Haba-Rodríguez J, Arcusa A, Chacón JI, Sánchez-Rovira P, Plazaola A, Muñoz M, Paré L, Parker JS, Ribelles N, Jimenez B, Bin Aiderus AA, Caballero R, Adamo B, Dowsett M, Carrasco E, Martín M, Dixon JM, Perou CM, Alba E.

Clin Cancer Res. 2017 Jun 15;23(12):3035-3044. doi: 10.1158/1078-0432.CCR-16-2092. Epub 2016 Nov 30.

28.
29.

Should patients with early breast cancer still be offered the choice of breast conserving surgery or mastectomy?

Johns N, Dixon JM.

Eur J Surg Oncol. 2016 Nov;42(11):1636-1641. doi: 10.1016/j.ejso.2016.08.016. Epub 2016 Aug 31. Review.

PMID:
27665053
30.

Contemporary social media engagement by breast surgeons.

Ekatah GE, Walker SG, McDonald JJ, Dixon JM, Brady RRW.

Breast. 2016 Dec;30:172-174. doi: 10.1016/j.breast.2016.09.010. Epub 2016 Oct 14.

PMID:
27750107
31.

Intra-operative assessment of excised breast tumour margins using ClearEdge imaging device.

Dixon JM, Renshaw L, Young O, Kulkarni D, Saleem T, Sarfaty M, Sreenivasan R, Kusnick C, Thomas J, Williams LJ.

Eur J Surg Oncol. 2016 Dec;42(12):1834-1840. doi: 10.1016/j.ejso.2016.07.141. Epub 2016 Aug 10.

PMID:
27591938
32.

Sentinel Lymph Node Biopsy in Breast Cancer Surgery.

Dixon JM.

Ann Surg Oncol. 2016 Oct;23(11):3426-3428. doi: 10.1245/s10434-016-5434-6. Epub 2016 Jul 22. No abstract available.

PMID:
27448117
33.

Tumour sampling method can significantly influence gene expression profiles derived from neoadjuvant window studies.

Pearce DA, Arthur LM, Turnbull AK, Renshaw L, Sabine VS, Thomas JS, Bartlett JM, Dixon JM, Sims AH.

Sci Rep. 2016 Jul 7;6:29434. doi: 10.1038/srep29434.

34.

Treatment with aromatase inhibitors stimulates the expression of epidermal growth factor receptor-1 and neuregulin 1 in ER positive/HER-2/neu non-amplified primary breast cancers.

Flågeng MH, Larionov A, Geisler J, Knappskog S, Prestvik WS, Bjørkøy G, Lilleng PK, Dixon JM, Miller WR, Lønning PE, Mellgren G.

J Steroid Biochem Mol Biol. 2017 Jan;165(Pt B):228-235. doi: 10.1016/j.jsbmb.2016.06.011. Epub 2016 Jun 22.

PMID:
27343990
35.

Association between underestimation of tumour size by imaging and incomplete excision in breast-conserving surgery for breast cancer.

Dixon JM, Newlands C, Dodds C, Thomas J, Williams LJ, Kunkler IH, Bing A, Macaskill EJ.

Br J Surg. 2016 Jun;103(7):830-8. doi: 10.1002/bjs.10126.

PMID:
27171027
36.

Importance of margin width in breast-conserving treatment of early breast cancer.

Bodilsen A, Bjerre K, Offersen BV, Vahl P, Amby N, Dixon JM, Ejlertsen B, Overgaard J, Christiansen P.

J Surg Oncol. 2016 May;113(6):609-15. doi: 10.1002/jso.24224. Epub 2016 Mar 16.

PMID:
26991020
37.

A study of margin width and local recurrence in breast conserving therapy for invasive breast cancer.

Dixon JM, Thomas J, Kerr GR, Williams LJ, Dodds C, Kunkler IH, Macaskill EJ.

Eur J Surg Oncol. 2016 May;42(5):657-64. doi: 10.1016/j.ejso.2016.02.008. Epub 2016 Feb 18.

PMID:
26944365
38.

A Rare Presentation of Chest Wall Chondrosarcoma as a Breast Mass.

Vaughan EM, Loh SF, Beesley M, West CC, Dixon JM.

Breast J. 2016 Mar-Apr;22(2):235-7. doi: 10.1111/tbj.12553. Epub 2016 Feb 4. No abstract available.

PMID:
26843126
39.
40.

Adaptation to AI Therapy in Breast Cancer Can Induce Dynamic Alterations in ER Activity Resulting in Estrogen-Independent Metastatic Tumors.

Varešlija D, McBryan J, Fagan A, Redmond AM, Hao Y, Sims AH, Turnbull A, Dixon JM, Ó Gaora P, Hudson L, Purcell S, Hill AD, Young LS.

Clin Cancer Res. 2016 Jun 1;22(11):2765-77. doi: 10.1158/1078-0432.CCR-15-1583. Epub 2016 Jan 13.

41.

Endocrine resistance in breast cancer--An overview and update.

Clarke R, Tyson JJ, Dixon JM.

Mol Cell Endocrinol. 2015 Dec 15;418 Pt 3:220-34. doi: 10.1016/j.mce.2015.09.035. Epub 2015 Oct 9. Review.

42.

Evaluation of carbonic anhydrase IX as a therapeutic target for inhibition of breast cancer invasion and metastasis using a series of in vitro breast cancer models.

Ward C, Meehan J, Mullen P, Supuran C, Dixon JM, Thomas JS, Winum JY, Lambin P, Dubois L, Pavathaneni NK, Jarman EJ, Renshaw L, Um IH, Kay C, Harrison DJ, Kunkler IH, Langdon SP.

Oncotarget. 2015 Sep 22;6(28):24856-70. doi: 10.18632/oncotarget.4498.

43.

Actinomyces Species Isolated from Breast Infections.

Bing AU, Loh SF, Morris T, Hughes H, Dixon JM, Helgason KO.

J Clin Microbiol. 2015 Oct;53(10):3247-55. doi: 10.1128/JCM.01030-15. Epub 2015 Jul 29.

44.

Standardization of pathologic evaluation and reporting of postneoadjuvant specimens in clinical trials of breast cancer: recommendations from an international working group.

Provenzano E, Bossuyt V, Viale G, Cameron D, Badve S, Denkert C, MacGrogan G, Penault-Llorca F, Boughey J, Curigliano G, Dixon JM, Esserman L, Fastner G, Kuehn T, Peintinger F, von Minckwitz G, White J, Yang W, Symmans WF; Residual Disease Characterization Working Group of the Breast International Group-North American Breast Cancer Group Collaboration.

Mod Pathol. 2015 Sep;28(9):1185-201. doi: 10.1038/modpathol.2015.74. Epub 2015 Jul 24.

45.

Intra-operative digital specimen radiology reduces re-operation rates in therapeutic mammaplasty for breast cancer.

Majdak-Paredes EJ, Schaverien MV, Szychta P, Raine C, Dixon JM.

Breast. 2015 Oct;24(5):556-9. doi: 10.1016/j.breast.2015.04.007. Epub 2015 Jun 26.

PMID:
26119619
46.

Accurate Prediction and Validation of Response to Endocrine Therapy in Breast Cancer.

Turnbull AK, Arthur LM, Renshaw L, Larionov AA, Kay C, Dunbier AK, Thomas JS, Dowsett M, Sims AH, Dixon JM.

J Clin Oncol. 2015 Jul 10;33(20):2270-8. doi: 10.1200/JCO.2014.57.8963. Epub 2015 Jun 1.

47.

Recommendations for standardized pathological characterization of residual disease for neoadjuvant clinical trials of breast cancer by the BIG-NABCG collaboration.

Bossuyt V, Provenzano E, Symmans WF, Boughey JC, Coles C, Curigliano G, Dixon JM, Esserman LJ, Fastner G, Kuehn T, Peintinger F, von Minckwitz G, White J, Yang W, Badve S, Denkert C, MacGrogan G, Penault-Llorca F, Viale G, Cameron D; Breast International Group-North American Breast Cancer Group (BIG-NABCG) collaboration.

Ann Oncol. 2015 Jul;26(7):1280-91. doi: 10.1093/annonc/mdv161. Epub 2015 May 27. Review.

48.

Meta-analysis of the effect of preoperative breast MRI on the surgical management of ductal carcinoma in situ.

Fancellu A, Turner RM, Dixon JM, Pinna A, Cottu P, Houssami N.

Br J Surg. 2015 Jul;102(8):883-93. doi: 10.1002/bjs.9797. Epub 2015 Apr 28. Review.

PMID:
25919321
49.

Integrative analyses identify modulators of response to neoadjuvant aromatase inhibitors in patients with early breast cancer.

López-Knowles E, Wilkerson PM, Ribas R, Anderson H, Mackay A, Ghazoui Z, Rani A, Osin P, Nerurkar A, Renshaw L, Larionov A, Miller WR, Dixon JM, Reis-Filho JS, Dunbier AK, Martin LA, Dowsett M.

Breast Cancer Res. 2015 Mar 11;17:35. doi: 10.1186/s13058-015-0532-0.

50.

Correction to Lancet Oncol 2015; 16: 266.

Kunkler IH, Williams LJ, Jack WJ, Cameron DA, Dixon JM; PRIME II investigators.

Lancet Oncol. 2015 Mar;16(3):e105. doi: 10.1016/S1470-2045(15)70094-X. No abstract available.

PMID:
25752559

Supplemental Content

Loading ...
Support Center